Violence continues in Ullal: Another youth stabbed near Dargah

Bengaluru, Apr 6: The Covid-19 Task Force aims to conduct 80,000 throat swab and blood tests over the next three weeks here.

According to Task Force Nodal Officer C N Manjunath an order for one lakh anti-body test kits has been placed, and was expected to arrive on April 12.

"From January 20 to March 23, more than 1.2 lakh people arrived at international airports from abroad. Of these, we have kept 37,358 under observation. The Health officials and personnel in fever clinics and hospitals are being trained to conduct the tests. There is no necessity to obtain a clearance to test people with suspected infection. Only laboratories need to get permission to test their blood and throat swab samples."

Bengaluru, Feb 15: The new Karnataka Minister for Forest Anand Singh on Friday said that he is ready for 'change in the portfolio' as opposition parties are leveling charges against Chief Minister B S Yediyurappa for appointing him, despite having 15 cases registered under Forest Act against him.

"If Chief Minister wants to change my portfolio, I am ready," he added.

Speaking to newsmen here, he said that there are 15 cases pending against him. The Legislator from Vijayanagara in Mine rich Ballari district said anyone can go through the Chargesheets and find out whether there are any direct charges against him. Claiming that the cases against him were 'minor violations', he had earlier linked them to traffic violations by a vehicle owner.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.